The Department of Surgery Resident Wellbeing Council
The Department of Surgery Resident Wellbeing Council exists to support all residents—junior and senior—in achieving optimal mental well-being during their training at Mass General and beyond.
Motaz Qadan, MD, PhD
Motaz Qadan, MD, PhD
Pancreatic Surgeon | Liver Surgeon
Gapontsev Family Endowed Chair in Surgical Oncology
Associate Professor of Surgery
Gapontsev Family Endowed Chair in Surgical Oncology
Associate Professor of Surgery
About Motaz Qadan, MD, PhD
Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist at the Massachusetts General Hospital (MGH). He is a high volume pancreas and liver specialized surgeon with excellent outcomes. Patient information videos about his common operations are included below:
Dr. Qadan's leadership positions include:
- Pancreas Cyst Multidisciplinary Clinic Director
- Hepatobiliary Surgery Director for Young Adult Colorectal Cancer Center
- Harvard Medical Student Advanced Surgical Clerkship Director
- Mass General Brigham Resident and Fellow Wellbeing Council Faculty Advisor
- Complex General Surgical Oncology Fellowship Program Director at the MGH
- Clinical Lead for Enhanced Recovery after Surgery (ERAS) in Pancreas Surgery
Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York and served as the educational coordinator during his fellowship.
Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the MGH in Boston.
Below are some additional sites of interest:
Departments, Centers, & Programs:
Clinical Interests:
- Pancreatic and hepatobiliary surgery
- Liver metastases
- Pancreatic cystic tumors
- Hepatocellular carcinoma, Cholangiocarcinoma, Liver tumors
- Liver surgery
- Pancreatic cancer
- Liver cancer
- Pancreatobiliary surgery
- Surgical oncology
- Minimally invasive surgery
- Robotic surgery
Treats:
- Adult
Locations
Boston: Massachusetts General Hospital
Department of Surgery
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-643-5153
Fax: 617-724-3895
Medical Education
- MD, University of Edinburgh
- PHD, University of Louisville
- Residency, Stanford University Hospital and Clinics
- Fellowship, Memorial Sloan Kettering Cancer Center
American Board Certifications
- Surgery, American Board of Surgery
- Complex General Surgical Oncology, American Board of Surgery
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicaid Dental
- Medicare
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan and introduction of Fingolimod (sphingosine-1-phosphate receptor 1 antagonist) for endothelial barrier disruption in orthotopic pancreatic tumor models.
Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.
Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.
Dr. Qadan is actively involved in many National societies and holds active leadership roles in several organizations. He has over 140 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center.
If you are interested in making a direct donation, please indicate the "Qadan Liver and Pancreas Research Fund". Donations are tax-deductible and handled by my colleague Ms. Meagan Coons of the MGH Development Office, 125 Nashua St, Suite 540, Boston, MA 02114. All donations are so greatly appreciated.